We view these in vitro data and our previous work assessing the efficacy of La inhibition in fibrous dysplasia of bone22 as proofs-of-principle supporting OC fusion as a viable mechanistic target in treating OC malformation and function in skeletal disease. This evidence concerns the gene BGLAP and bone disorder.